These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7035669)

  • 1. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
    Kovács G; Simonidesz V; Tömösközi I; Körmöczy P; Székely I; Papp-Behr A; Stadler I; Szekeres L; Papp G
    J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
    [No Abstract]   [Full Text] [Related]  

  • 2. Syntheses and biological activities of some prostacyclin analogs.
    Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
    [No Abstract]   [Full Text] [Related]  

  • 3. 11- and 15-deoxy-carboprostacyclins: hypothetic prostacyclin antagonists.
    Mongelli N; Magni O; Gandolfi C; Grossoni M; Ceserani R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():281-5. PubMed ID: 6221538
    [No Abstract]   [Full Text] [Related]  

  • 4. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a highly potent analogue of prostacyclin, (-)-5-methyleneisocarbacyclin.
    Amemiya S; Koyama K; Saito S; Kojima K
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4403-5. PubMed ID: 3549013
    [No Abstract]   [Full Text] [Related]  

  • 6. Syntheses of 13-oxa- and 13-thiaprostacyclins: biologically potent analogs of prostacyclin.
    Novák L; Aszódi J; Stadler I; Körmöczy P; Simonidesz V; Szántay C
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():275-80. PubMed ID: 6221537
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
    Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
    Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
    [No Abstract]   [Full Text] [Related]  

  • 8. 20-Methyl-prostacyclin analogs--a two stage screening procedure for biological properties.
    Gandolfi CA; Gryglewski RJ
    Pharmacol Res Commun; 1978 Nov; 10(10):885-96. PubMed ID: 366628
    [No Abstract]   [Full Text] [Related]  

  • 9. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostacyclin in cardiovascular diseases].
    Kishi Y; Numano F
    Kokyu To Junkan; 1985 Jul; 33(7):865-9. PubMed ID: 3903901
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel prostaglandin endoperoxide mimic, prostaglandin F2alpha acetal.
    Portoghese PS; Larson DL; Abatjoglou AG
    J Med Chem; 1977 Feb; 20(2):320-1. PubMed ID: 836508
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
    [No Abstract]   [Full Text] [Related]  

  • 14. 10,10-Difluoro-13-dehydroprostacyclin: a chemically and metabolically stabilized potent prostacyclin.
    Fried J; Mitra DK; Nagarajan M; Mehrotra MM
    J Med Chem; 1980 Mar; 23(3):234-7. PubMed ID: 6988588
    [No Abstract]   [Full Text] [Related]  

  • 15. Designing prostacyclin analogues.
    Flohé L; Böhlke H; Frankus E; Kim SM; Lintz W; Loschen G; Michel G; Müller B; Schneider J; Seipp U
    Arzneimittelforschung; 1983; 33(9):1240-8. PubMed ID: 6315026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and antiaggregation activity of prostacyclin analogs. 1. Bicyclo [3.2.0] heptane analogs].
    Lopp MI; Miuraus AI; Parve OV; Vialimiaé TK; Lopp AKh
    Bioorg Khim; 1988 Feb; 14(2):222-31. PubMed ID: 3289544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6,9-thiaprostacyclin. A stable and biologically potent analogue of prostacyclin (PGI2).
    Nicolaou KC; Barnette WE; Gasic GP; Magolda RL
    J Am Chem Soc; 1977 Nov; 99(23):7736-8. PubMed ID: 334822
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.